SDZXF (Sandoz Group AG) Common Stock: $25 Mil (As of Dec. 2025)


SDZXF Sandoz Group AG SDZXF
18 GF Score
Price $89.55
! 6 Warning Signs
View Full Analysis

What is Sandoz Group AG Common Stock?

Sandoz Group AG SDZXF 18 Common Stock is $25 Mil as of Dec. 2025. GuruFocus rates SDZXF with a GF Score™ of 18/100. The stock has 6 warning signs investors should review.

Sandoz Group AG's quarterly common stock stayed the same from Dec. 2024 ($25 Mil) to Jun. 2025 ($25 Mil) and stayed the same from Jun. 2025 ($25 Mil) to Dec. 2025 ($25 Mil).

Sandoz Group AG's annual common stock increased from Dec. 2023 ($24 Mil) to Dec. 2024 ($25 Mil) but then stayed the same from Dec. 2024 ($25 Mil) to Dec. 2025 ($25 Mil).

Sandoz Group AG Common Stock Historical Data

* Premium members only.

The historical data trend for Sandoz Group AG's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sandoz Group AG Common Stock Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Common Stock
8,748.00 24.00 25.00 25.00

Sandoz Group AG Semi-Annual Data
Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial 24.00 24.00 25.00 25.00 25.00
SDZXF
18GF Score
Sandoz Group AG SDZXF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sandoz Group AG Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $25 Mil mean?
Sandoz Group AG (SDZXF) has a Common Stock of $25 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sandoz Group AG and its competitors.
Is Sandoz Group AG's Common Stock too high?
Sandoz Group AG's current Common Stock is $25 Mil. Overall, Sandoz Group AG has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Sandoz Group AG's Common Stock compare to ZTS and UTHR?
Sandoz Group AG's Common Stock of $25 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Sandoz Group AG and its competitors. Sandoz Group AG's current Common Stock is $25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sandoz Group AG stock overvalued right now?
Sandoz Group AG (SDZXF) has a current Common Stock of $25 Mil. The current Common Stock is $25 Mil. Sandoz Group AG's overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Sandoz Group AG (SDZXF), the current Common Stock is $25 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Sandoz Group AG Business Description

Address Centralbahnstrasse 4, Basel, CHE, 4051
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $11 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among the leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006, as well as the first US biosimilar, Zarxio, in 2015. It has over 10 launched biosimilars in a number of markets and over 20 assets in its pipeline.
18GF Score

Get the complete analysis for SDZXF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$89.55
Price